Evidence map›Paper›PMID 34495394›Full record

ArticleMikrochimica acta2021

Development of electrochemical biosensors for simultaneous multiplex detection of microRNA for breast cancer screening.

Dechnarong Pimalai, Thitirat Putnin, Wassa Waiwinya, Chuleekorn Chotsuwan, Noppadol Aroonyadet, Deanpen Japrung

Abstract read
PubMed Publisher
In one paragraph

Article in Mikrochimica acta, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
2.8field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 50 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Review
  5. Review
  6. Review
  7. Article
  8. Review
  9. Review
  10. Review
  11. Multiplexed electrochemical assays for clinical applications.Current opinion in electrochemistry · 2023
    Article
  12. Review
  13. Review
  14. An ultrasensitive hairpin sensor based on g-CAnalytical and bioanalytical chemistry · 2022
    Article
  15. Article
  16. Article
  17. Review
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Dechnarong PimalaiNational Nanotechnology Center (NANOTEC), National Science and Technology Development Agency (NSTDA), Pathum Thani, 12120, Thailand.
Thitirat PutninNational Nanotechnology Center (NANOTEC), National Science and Technology Development Agency (NSTDA), Pathum Thani, 12120, Thailand.
Wassa WaiwinyaNational Nanotechnology Center (NANOTEC), National Science and Technology Development Agency (NSTDA), Pathum Thani, 12120, Thailand.
Chuleekorn ChotsuwanNational Nanotechnology Center (NANOTEC), National Science and Technology Development Agency (NSTDA), Pathum Thani, 12120, Thailand.
Noppadol AroonyadetNational Nanotechnology Center (NANOTEC), National Science and Technology Development Agency (NSTDA), Pathum Thani, 12120, Thailand.
Deanpen JaprungNational Nanotechnology Center (NANOTEC), National Science and Technology Development Agency (NSTDA), Pathum Thani, 12120, Thailand. deanpen@nanotec.or.th.
National Nanotechnology Center · THNational Science and Technology Development Agency · TH

Funding

National Nanotechnology Center P1851652
6 · The paper itself

Abstract

A highly sensitive electrochemical biosensors has been developed for the detection of multiplex micro ribonucleic acids (miRNAs) by modifying an electrode with reduced graphene oxide/poly(2-aminobenzylamine)/gold nanoparticles and adopting porous, hollow silver-gold nanoparticles as tagged labeling with metal ions. In addition, an anti-deoxyribonucleic acid (DNA)-RNA hybrid [S9.6] antibody was used to detect different hybridized capture DNAs and miRNAs that can detect multiple miRNAs simultaneously. The developed electrochemical platform exhibits high selectivity, stability, and sensitivity with a wide linear range from 1 fM to 10 nM and a low detection limit of 0.98 fM, 3.58 fM, and 0.25 fM for miRNA-155, miRNA-21, and miRNA-16, respectively. In addition, the proposed electrochemical biosensor capable for the simultaneous detection of miRNA-155, miRNA-16, and miRNA-21, which are breast cancer biomarkers, in normal human serum, can be adopted and potentially used for breast cancer screening.

Indexed as

Antibodies, ImmobilizedBiomarkers, TumorBiosensing TechniquesBreast NeoplasmsElectrochemical TechniquesGoldHumansLimit of DetectionMetal NanoparticlesMicroRNAsPolyaminesPorositySilverAntibodies, ImmobilizedBiomarkers, TumorGoldMicroRNAsMIRN155 microRNA, humanMIRN16 microRNA, humanMIRN21 microRNA, humanPolyaminesSilverBreast cancerElectrochemical biosensorsmiRNA multiplex detectionNanoparticle modified electrodeScreen printed carbon electrode

Identifiers

PMID34495394
OpenAlexW3197536959

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.